Identification of a robust signature for clinical outcomes and immunotherapy response in gastric cancer: based on N6-methyladenosine related long noncoding RNAs

BACKGROUND: Gastric cancer (GC) is a globally prevalent cancer, ranking fifth for incidence and fourth for mortality worldwide. The N6-methyladenosine (m(6)A) related long noncoding RNAs (lncRNAs) were widely investigated in recent studies. Nevertheless, the underlying prognostic implication and tum...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Tenghui, Xu, Dong, Zhu, Jun, Li, Jipeng, Liu, Lei, Deng, Yanchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365962/
https://www.ncbi.nlm.nih.gov/pubmed/34399770
http://dx.doi.org/10.1186/s12935-021-02146-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8365962/
https://www.ncbi.nlm.nih.gov/pubmed/34399770
http://dx.doi.org/10.1186/s12935-021-02146-w

Ejemplares similares